You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR TERAZOSIN HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for TERAZOSIN HYDROCHLORIDE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00007592 ↗ Hypertension Screening and Treatment Program Completed US Department of Veterans Affairs 1989-06-01 Hypertension is one of the most common medical problems in the United States and in the VA health care system. It has been well-documented that hypertension can be effectively treated. However, there remain important unresolved clinical questions in the area of antihypertensive treatment. For example, how much is mortality affected by visit compliance, blood pressure control and type of antihypertensive agent? Or, are some regimens associated with more morbidity than others? Or, are there inexpensive regimens that are as effective as more expensive regimens? The amount of data that is available from this demonstration project (currently 6,100 patients) will help address these questions. The answers to these questions should result in better care for veterans with hypertension.
NCT00007592 ↗ Hypertension Screening and Treatment Program Completed VA Office of Research and Development 1989-06-01 Hypertension is one of the most common medical problems in the United States and in the VA health care system. It has been well-documented that hypertension can be effectively treated. However, there remain important unresolved clinical questions in the area of antihypertensive treatment. For example, how much is mortality affected by visit compliance, blood pressure control and type of antihypertensive agent? Or, are some regimens associated with more morbidity than others? Or, are there inexpensive regimens that are as effective as more expensive regimens? The amount of data that is available from this demonstration project (currently 6,100 patients) will help address these questions. The answers to these questions should result in better care for veterans with hypertension.
NCT00201630 ↗ Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy Unknown status Sanofi Phase 3 2005-09-01 To asess the efficacy of Uroxatrol, an alpha blocker in men undergoing prostate brachytherapy to treat prostate cancer, and whether the use of Uroxatrol in advance of the brachytherapy is better or not than starting it on the day of surgery.
NCT00201630 ↗ Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy Unknown status New York Prostate Institute Phase 3 2005-09-01 To asess the efficacy of Uroxatrol, an alpha blocker in men undergoing prostate brachytherapy to treat prostate cancer, and whether the use of Uroxatrol in advance of the brachytherapy is better or not than starting it on the day of surgery.
NCT00237510 ↗ Pilot Study of Terazosin in Treatment of Antidepressant Induced Excessive Sweating Completed Thomas Jefferson University N/A 2005-05-01 This study is based on the hypothesis that terazosin, a blocker of alpha-1 receptors, will be effective in reducing excessive sweating caused by antidepressant treatment, and will have minimal adverse effects.
NCT00381108 ↗ Study of the Effects of Pomegranate Tablets on Enlarged Prostates Unknown status Jarrow Pharmaceuticals Phase 1 2005-09-01 To determine whether pomegranate tablets have a therapeutic effect on Benign Prostatic Hyperplasia.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for TERAZOSIN HYDROCHLORIDE

Condition Name

Condition Name for TERAZOSIN HYDROCHLORIDE
Intervention Trials
Benign Prostatic Hyperplasia 3
Parkinson Disease 2
Pre-motor Parkinson's Disease 2
Hypertension 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for TERAZOSIN HYDROCHLORIDE
Intervention Trials
Prostatic Hyperplasia 5
Hyperplasia 5
Parkinson Disease 4
Hyperhidrosis 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for TERAZOSIN HYDROCHLORIDE

Trials by Country

Trials by Country for TERAZOSIN HYDROCHLORIDE
Location Trials
United States 27
China 4
Korea, Republic of 2
Canada 1
Iran, Islamic Republic of 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for TERAZOSIN HYDROCHLORIDE
Location Trials
Pennsylvania 4
Iowa 4
California 4
Tennessee 2
Florida 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for TERAZOSIN HYDROCHLORIDE

Clinical Trial Phase

Clinical Trial Phase for TERAZOSIN HYDROCHLORIDE
Clinical Trial Phase Trials
Phase 4 4
Phase 3 1
Phase 2/Phase 3 1
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for TERAZOSIN HYDROCHLORIDE
Clinical Trial Phase Trials
Completed 10
Unknown status 5
Not yet recruiting 3
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TERAZOSIN HYDROCHLORIDE

Sponsor Name

Sponsor Name for TERAZOSIN HYDROCHLORIDE
Sponsor Trials
Thomas Jefferson University 3
Cedars-Sinai Medical Center 2
University of Iowa 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for TERAZOSIN HYDROCHLORIDE
Sponsor Trials
Other 35
Industry 4
U.S. Fed 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.